Association of Developmental Venous Anomalies with Demyelinating Lesions in Patients with Multiple Sclerosis

References

1. 1.↵
   2. Rindfleisch E

   . Histologisches Detail zu der grauen Degeneration von Gehirn und Rückenmark. (Zugleich ein Beitrag zu der Lehre von der Entstehung und Verwandlung der Zelle.) Archiv für pathologische Anatomie und Physiologie und für klinische Medicin 1863;26:474–83 doi:10.1007/bf01878008

   CrossRef
2. 2.↵
   2. Rae-Grant AD,
   3. Wong C,
   4. Bernatowicz R, et al

   . Observations on the brain vasculature in multiple sclerosis: a historical perspective. Mult Scler Relat Disord 2014;3:156–62 doi:10.1016/j.msard.2013.08.005 pmid:25878003

   CrossRefPubMed
3. 3.↵
   2. Solomon AJ,
   3. Schindler MK,
   4. Howard DB, et al

   . “Central vessel sign” on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine. Ann Clin Transl Neurol 2016;3:82–87 doi:10.1002/acn3.273 pmid:26900578

   CrossRefPubMed
4. 4.↵
   2. Mistry N,
   3. Abdel-Fahim R,
   4. Samaraweera A, et al

   . Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions. Mult Scler 2016;22:1289–96 doi:10.1177/1352458515616700 pmid:26658816

   CrossRefPubMed
5. 5.↵
   2. Tallantyre EC,
   3. Brookes MJ,
   4. Dixon JE, et al

   . Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology 2008;70:2076–78 doi:10.1212/01.wnl.0000313377.49555.2e pmid:18505982

   FREE Full Text
6. 6.↵
   2. Sati P,
   3. Oh J,
   4. Constable RT, et al

   . The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol 2016;12:714–22 doi:10.1038/nrneurol.2016.166 pmid:27834394

   CrossRefPubMed
7. 7.↵
   2. Gaitán MI,
   3. Sati P,
   4. Inati SJ, et al

   . Initial investigation of the blood-brain barrier in MS lesions at 7 Tesla. Mult Scler 2013;19:1068–73 doi:10.1177/1352458512471093 pmid:23246799

   CrossRefPubMed
8. 8.↵
   2. Samaraweera AP,
   3. Clarke MA,
   4. Whitehead A, et al

   . The central vein sign in multiple sclerosis lesions is present irrespective of the T2* sequence at 3 T. J Neuroimaging 2017;27:114–21 doi:10.1111/jon.12367 pmid:27300318

   CrossRefPubMed
9. 9.↵
   2. Zhao G,
   3. Li DK,
   4. Traboulsee T, et al

   . Developmental venous anomalies (venous angiomas) on MRI are more common in patients with multiple sclerosis. In: Proceedings of the International Society for Magnetic Resonance in Medicine Twelfth Scientific Meeting, Kyoto, Japan. May 15–21, 2004
10. 10.↵
    2. Jung G,
    3. Schroder R,
    4. Lanfermann H, et al

    . Evidence of acute demyelination around a developmental venous anomaly: magnetic resonance imaging findings. Invest Radiol 1997;32:575–77 doi:10.1097/00004424-199709000-00010 pmid:9291046

    CrossRefPubMed
11. 11.↵
    2. Filippi M,
    3. Rocca MA,
    4. Ciccarelli O, et al

    . MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol 2016;15:292–303 doi:10.1016/S1474-4422(15)00393-2 pmid:26822746

    CrossRefPubMed
12. 12.↵
    2. Lane JI,
    3. Bolster B,
    4. Campeau NG, et al

    . Characterization of multiple sclerosis plaques using susceptibility-weighted imaging at 1.5 T: can perivenular localization improve specificity of imaging criteria? J Comput Assist Tomogr 2015;39:317–20 doi:10.1097/RCT.0000000000000233 pmid:25783798

    CrossRefPubMed
13. 13.↵
    2. Zhang Y,
    3. Metz LM

    . Dominant perivenular enhancement of tumefactive demyelinating lesions in multiple sclerosis. Neurology 2010;75:1396 doi:10.1212/WNL.0b013e3181f736d3 pmid:20938034

    FREE Full Text
14. 14.↵
    2. Tan IL,
    3. van Schijndel RA,
    4. Pouwels PJ, et al

    . MR venography of multiple sclerosis. AJNR Am J Neuroradiol 2000;21:1039–42 pmid:10871010

    Abstract/FREE Full Text
15. 15.↵
    2. Dal-Bianco A,
    3. Hametner S,
    4. Grabner G, et al

    . Veins in plaques of multiple sclerosis patients–a longitudinal magnetic resonance imaging study at 7 Tesla. Eur Radiol 2015;25:2913–20 doi:10.1007/s00330-015-3719-y pmid:25903703

    CrossRefPubMed
16. 16.↵
    2. Hourani R,
    3. Brant LJ,
    4. Rizk T, et al

    . Can proton MR spectroscopic and perfusion imaging differentiate between neoplastic and nonneoplastic brain lesions in adults? AJNR Am J Neuroradiol 2008;29:366–72 doi:10.3174/ajnr.A0810 pmid:18055564

    Abstract/FREE Full Text
17. 17.↵
    2. Nagatani K,
    3. Osada H,
    4. Takeuchi S, et al

    . Surgical resection of developmental venous anomaly causing massive intracerebral haemorrhage: a case report. Br J Neurosurg 2014;28:116–18 doi:10.3109/02688697.2013.815318 pmid:23841660

    CrossRefPubMed
18. 18.↵
    2. Amuluru K,
    3. Al-Mufti F,
    4. Hannaford S, et al

    . Symptomatic infratentorial thrombosed developmental venous anomaly: case report and review of the literature. Interv Neurol 2016;4:130–37 doi:10.1159/000444028 pmid:27051409

    CrossRefPubMed
19. 19.↵
    2. Rammos SK,
    3. Maina R,
    4. Lanzino G

    . Developmental venous anomalies: current concepts and implications for management. Neurosurgery 2009;65:20–29; discussion 29–30 doi:10.1227/01.NEU.0000347091.06694.3E pmid:19574822

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Larvie M,
    3. Timerman D,
    4. Thum JA

    . Brain metabolic abnormalities associated with developmental venous anomalies. AJNR Am J Neuroradiol 2015;36:475–80 doi:10.3174/ajnr.A4172 pmid:25477358

    Abstract/FREE Full Text
21. 21.↵
    2. Jung HN,
    3. Kim ST,
    4. Cha J, et al

    . Diffusion and perfusion MRI findings of the signal-intensity abnormalities of brain associated with developmental venous anomaly. AJNR Am J Neuroradiol 2014;35:1539–42 doi:10.3174/ajnr.A3900 pmid:24651815

    Abstract/FREE Full Text
22. 22.↵
    2. Matthews PM,
    3. Roncaroli F,
    4. Waldman A, et al

    . A practical review of the neuropathology and neuroimaging of multiple sclerosis. Pract Neurol 2016;16:279–87 doi:10.1136/practneurol-2016-001381 pmid:27009310

    Abstract/FREE Full Text
23. 23.↵
    2. Tanaka R,
    3. Iwasaki Y,
    4. Koprowski H

    . Ultrastructural studies of perivascular cuffing cells in multiple sclerosis brain. Am J Pathol 1975;81:467–78 pmid:1211421

    PubMedWeb of Science
24. 24.↵
    2. Adams CW

    . The onset and progression of the lesion in multiple sclerosis. J Neurol Sci 1975;25:165–82 doi:10.1016/0022-510X(75)90138-0 pmid:1151432

    CrossRefPubMed
25. 25.↵
    2. Minagar A,
    3. Alexander JS

    . Blood-brain barrier disruption in multiple sclerosis. Mult Scler 2003;9:540–49 doi:10.1191/1352458503ms965oa pmid:14664465

    CrossRefPubMedWeb of Science